• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

second-sight-medical

Second Sight gains FDA nod for retinal system that may never be produced

March 5, 2021 By Nancy Crotti

Second Sight Medical  (NSDQ: EYES) today announced that the FDA has approved its Argus 2s retinal prosthesis system, but questions remain about whether it will ever be manufactured. The past year has been tough for Second Sight. The company announced in March 2020 that it would wind down its operations amid the financial shock of […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, Neuromodulation/Neurostimulation, Optical/Ophthalmic, Regulatory/Compliance Tagged With: FDA, Pixium Vision, Second Sight, second-sight-medical

Amazon-Berkshire-JPM healthcare bet taps Comcast’s Stoddard for COO | Personnel Moves, Sept. 10, 2018

September 10, 2018 By Brad Perriello

Amazon-Berkshire-JPM healthcare bet taps Comcast’s Stoddard for COO The healthcare joint venture started by Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan tapped former Comcast executive Jack Stoddard to be its COO, reporting to CEO Dr. Atul Gawande. Stoddard was a co-founder of Accolade, a startup backed by the cable giant that helps workers manage their health […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News Tagged With: Amazon, Berkshire Hathaway, conformis, DarioHealth Corp, General Electric, gerresheimer, JP Morgan Chase, Lantheus, Personnel Moves, Philips, Phillips-Medisize, second-sight-medical, starkey

NinePoint Medical lifts Namati to the corner office | Personnel Moves – July 10, 2018

July 10, 2018 By Fink Densford

NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, […]

Filed Under: Business/Financial News Tagged With: Alfred Mann Foundation, Bonesupport, Cutera Inc., Endologix, GE Healthcare, iRhythm Technologies Inc., Merit Medical Systems, NinePoint Medical Inc., Personnel Moves, RTI Surgical, SeaSpine, second-sight-medical, Titan Spine, Xtant Medical, Zimmer Biomet

FDA clears Second Sight IDE trial of next-gen Orion cortical visual prosthesis

August 28, 2017 By Fink Densford

Second Sight Medical (NSDQ:EYES) said today it won FDA investigational device exemption to initiate a feasibility clinical study of its Orion cortical visual prosthesis system. The conditional approval gives the Sylmar, Calif.-based company clearance to enroll up to 5 patients at 2 US sites, but requires that the company conduct additional device testing and “address outstanding […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Optical/Ophthalmic, Prosthetics Tagged With: second-sight-medical

Second Sight Medical enters Russian market

July 26, 2017 By Fink Densford

Second Sight Medical (NSDQ:EYES) said today it entered the Russian market, with the 1st patient treated with its Argus II Retinal Prosthesis System in Moscow. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception of light patterns to […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: second-sight-medical

Second Sight Medical wins expanded CMS coverage for Argus II

July 3, 2017 By Fink Densford

Second Sight Medical (NSDQ:EYES) said today its Argus II retinal prosthesis system won expanded reimbursement coverage from the Centers for Medicare and Medicaid Services in 11 additional states and the District of Columbia. With the expansion, the Sylmar, Calif.-based company said it’s Argus II device is now reimbursable in 7 of the 12 Medicare Administrative Contractor jurisdictions, […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: second-sight-medical

Second Sight shares drop on Q1 miss

May 4, 2017 By Fink Densford

Shares in Second Sight Medical (NSDQ:EYES) have dropped today after the medical device maker missed expectations on Wall Street with its 1st quarter results. The Sylmar, Calif-based company posted losses of $7.5 million, or 16¢ per share, on sales of $1 million for the 3 months ended March 31, seeing losses grow 29.8% while sales […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup Tagged With: second-sight-medical

7 medtech stories we missed this week: April 14, 2017

April 14, 2017 By Danielle Kirsh

From FDA approvals to business expansion plans, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. BioTelemetry launches offer to acquire LifeWatch BioTelemetry and LifeWatch announced in an April 9 press release that the 2 companies have entered a transaction agreement that states BioTelemetry will launch a tender offer […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development Tagged With: Acelity, BioTelemetry, CollPlant, LifeWatch, MedTech, second-sight-medical, Sight Sciences, Toshiba

Terumo taps DeRyke for CEO | Personnel Moves | April 7, 2017

April 7, 2017 By Brad Perriello

Terumo Corp. (TYO:4543) said yesterday it tapped Rob DeRyke as its new CV group prez & CEO, effective April 1, 2017, succeeding a retiring Mark Sutter. Prior to his appointment, DeRyke operated as Terumo CV group electromechanical systems division prez, the company said. “Under his leadership, Rob brought stability and improved profitability to the business,” Terumo […]

Filed Under: Business/Financial News Tagged With: access-vascular, Alphatec, Integrated Healing Technologies, MedPlast, Personnel Moves, Providence Medical, second-sight-medical, Sight Sciences, Terumo, Varian Medical Systems

Second Sight Medical closes $20m rights offering

March 9, 2017 By Fink Densford

Second Sight Medical (NSDQ:EYES) said today it closed a previously announced rights offering, retaining approximately $20.1 million with proceeds slated to support development and improvement of its Argus II retinal prosthesis. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: second-sight-medical

Second Sight announces upcoming rights offering

February 6, 2017 By Fink Densford

Second Sight Medical (NSDQ:EYES) today released information on an upcoming rights offering, with plans to open on February 10, with proceeds slated to support development and improvement of its Argus II retinal prosthesis. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: second-sight-medical

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 6
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy